132 related articles for article (PubMed ID: 27600078)
1. Small-Molecule Inhibition of Rho/MKL/SRF Transcription in Prostate Cancer Cells: Modulation of Cell Cycle, ER Stress, and Metastasis Gene Networks.
Evelyn CR; Lisabeth EM; Wade SM; Haak AJ; Johnson CN; Lawlor ER; Neubig RR
Microarrays (Basel); 2016 May; 5(2):. PubMed ID: 27600078
[TBL] [Abstract][Full Text] [Related]
2. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent.
Selvaraj A; Prywes R
BMC Mol Biol; 2004 Aug; 5():13. PubMed ID: 15329155
[TBL] [Abstract][Full Text] [Related]
4. The myocardin-related transcription factor MKL co-regulates the cellular levels of two profilin isoforms.
Joy M; Gau D; Castellucci N; Prywes R; Roy P
J Biol Chem; 2017 Jul; 292(28):11777-11791. PubMed ID: 28546428
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function.
Patyal P; Zhang X; Verma A; Azhar G; Wei JY
Cells; 2024 Feb; 13(5):. PubMed ID: 38474356
[TBL] [Abstract][Full Text] [Related]
6. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the serum response factor coactivator megakaryoblastic leukemia (MKL) in the activin-regulated dendritic complexity of rat cortical neurons.
Ishikawa M; Nishijima N; Shiota J; Sakagami H; Tsuchida K; Mizukoshi M; Fukuchi M; Tsuda M; Tabuchi A
J Biol Chem; 2010 Oct; 285(43):32734-32743. PubMed ID: 20709749
[TBL] [Abstract][Full Text] [Related]
8. Actin-mediated gene expression depends on RhoA and Rac1 signaling in proximal tubular epithelial cells.
Giehl K; Keller C; Muehlich S; Goppelt-Struebe M
PLoS One; 2015; 10(3):e0121589. PubMed ID: 25816094
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Dendritic Synaptic Morphology and Transcription by the SRF Cofactor MKL/MRTF.
Tabuchi A; Ihara D
Front Mol Neurosci; 2021; 14():767842. PubMed ID: 34795561
[TBL] [Abstract][Full Text] [Related]
10. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression.
Cen B; Selvaraj A; Prywes R
J Cell Biochem; 2004 Sep; 93(1):74-82. PubMed ID: 15352164
[TBL] [Abstract][Full Text] [Related]
11. MKL/SRF and Bcl6 mutual transcriptional repression safeguards the fate and positioning of neocortical progenitor cells mediated by RhoA.
Cossard A; Stam K; Smets A; Jossin Y
Sci Adv; 2023 Nov; 9(46):eadd0676. PubMed ID: 37967194
[TBL] [Abstract][Full Text] [Related]
12. Galphaz inhibits serum response factor-dependent transcription by inhibiting Rho signaling.
Dutt P; Jaffe AB; Merdek KD; Hall A; Toksoz D
Mol Pharmacol; 2004 Dec; 66(6):1508-16. PubMed ID: 15326221
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological intervention of MKL/SRF signaling by CCG-1423 impedes endothelial cell migration and angiogenesis.
Gau D; Veon W; Capasso TL; Bottcher R; Shroff S; Roman BL; Roy P
Angiogenesis; 2017 Nov; 20(4):663-672. PubMed ID: 28638990
[TBL] [Abstract][Full Text] [Related]
14. Rho/SRF Inhibitor Modulates Mitochondrial Functions.
Patyal P; Nguyen B; Zhang X; Azhar G; Ameer FS; Verma A; Crane J; Kc G; Che Y; Wei JY
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232837
[TBL] [Abstract][Full Text] [Related]
15. Formin-like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer.
Zeng Y; Xie H; Qiao Y; Wang J; Zhu X; He G; Li Y; Ren X; Wang F; Liang L; Ding Y
Cancer Sci; 2015 Oct; 106(10):1385-93. PubMed ID: 26258642
[TBL] [Abstract][Full Text] [Related]
16. [Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].
Han YL; Yu HB; Yan CH; Meng ZM; Zhang XL; Kang J; Li SH; Wang SW
Sheng Li Xue Bao; 2005 Jun; 57(3):295-302. PubMed ID: 15968423
[TBL] [Abstract][Full Text] [Related]
17. MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3.
Xiang Y; Liao XH; Yu CX; Yao A; Qin H; Li JP; Hu P; Li H; Guo W; Gu CJ; Zhang TC
Exp Cell Res; 2017 Aug; 357(1):135-144. PubMed ID: 28499590
[TBL] [Abstract][Full Text] [Related]
18. Umbilical cord/placenta-derived mesenchymal stem cells inhibit fibrogenic activation in human intestinal myofibroblasts via inhibition of myocardin-related transcription factor A.
Choi YJ; Koo JB; Kim HY; Seo JW; Lee EJ; Kim WR; Cho JY; Hahm KB; Hong SP; Kim DH; Yoo JH
Stem Cell Res Ther; 2019 Sep; 10(1):291. PubMed ID: 31547873
[TBL] [Abstract][Full Text] [Related]
19. CCG-1423-derived compounds reduce global RNA synthesis and inhibit transcriptional responses.
Prajapati B; Sokolova M; Sidorenko E; Kyriacou M; Kyheröinen S; Vihervaara A; Vartiainen MK
J Cell Sci; 2024 Jun; ():. PubMed ID: 38841882
[TBL] [Abstract][Full Text] [Related]
20. Rnd3/RhoE expression is regulated by G-actin through MKL1-SRF signaling pathway.
Piquet L; Robbe T; Neaud V; Basbous S; Rosciglione S; Saltel F; Moreau V
Exp Cell Res; 2018 Sep; 370(2):227-236. PubMed ID: 29940177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
